A Randomized Phase II Presurgical Trial of Weekly Low-Dose Tamoxifen Versus Raloxifene Versus Placebo in Premenopausal Women With Estrogen Receptor-Positive Breast Cancer

Breast Cancer Research - United Kingdom
doi 10.1186/bcr3439
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Medical Oncologists’ Perception of Anti-Estrogen Therapy Benefit in Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer

Annals of Oncology
MedicineOncologyHematology
2018English

Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Dicer Expression in Estrogen Receptor–positive Versus Triple-Negative Breast Cancer: An Antibody Comparison

Human Pathology
Forensic MedicinePathology
2016English

Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor–Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Raptor Localization Predicts Prognosis and Tamoxifen Response in Estrogen Receptor-Positive Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2017English

Nogo-B Receptor Increases the Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2018English

Oncofertility Counselling in Premenopausal Women With HER2-positive Breast Cancer

Oncotarget
Oncology
2019English

Randomized, Phase IIb Study of Low-Dose Cytarabine and Lintuzumab Versus Low-Dose Cytarabine and Placebo in Older Adults With Untreated Acute Myeloid Leukemia

Haematologica
Hematology
2012English

Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy